- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02999802
Nutrient Sensing & Signaling in Aging Muscle
June 11, 2018 updated by: The University of Texas Medical Branch, Galveston
This research seeks to better understand how cellular and molecular bases of changes associated with aging contribute to decreased function and increased incidence of disease.
Specific mechanism in muscle responsible for anabolic resistance - a key component of sarcopenia and frailty - will be identified.
The proposed research is relevant to public health because the discovery of new targets for interventions and novel therapeutics to improve muscle strength and function, prevent falls, and reduce physical dependency will improve the healthspan and quality of life in older adults by improving their physical function and ability to remain independent and healthy for a longer period of time.
Study Overview
Detailed Description
Anabolic resistance to nutrition is the reduced ability of skeletal muscle to increase protein synthesis in response to feeding.
It is a major contributor to muscle atrophy in aging, inactivity, burns, trauma, and cancer cachexia.
The effects of anabolic resistance on health and physical function are important.
For example, the loss of muscle mass and strength with aging (sarcopenia) increases the risk for falls, physical dependency and morbidity in older adults.
A major determinant of muscle size is muscle protein content, which is controlled by the fine balance between protein synthesis and breakdown.
Recently, investigators have found that amino acids and exercise independently increase muscle protein synthesis and overall anabolism by activating the mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway in humans.
Aging and inactivity reduce these anabolic effects, but the underlying mechanisms of anabolic resistance are not known.
The purpose of this application is to better understand how anabolic resistance develops in skeletal muscle.
The long-term goal is to identify specific molecular targets for the development of evidence-based clinical interventions to counteract anabolic resistance and muscle wasting in clinical populations.
Here, investigators will focus on one potential mechanisms underlying anabolic resistance to amino acids: activation of mTORC1 in human muscle cells.
The central hypothesis is that the physical activity restores mTORC1 signaling which is the primary contributor to anabolic resistance in human skeletal muscle.
Investigators will test this hypothesis in healthy subjects with the following specific aim: Determine the effect of increasing habitual physical activity on anabolic resistance.
Investigators will study human subjects utilizing stable isotopes model to measure amino acid kinetics and muscle protein metabolism in combination with molecular analysis of muscle to determine the regulatory role of amino acids, physical inactivity, and amino acid transporter functional activity on mTORC1.
The proposed approach is innovative because it represents a new and substantial departure from the status quo as investigators will examine the underlying mechanisms of anabolic resistance to nutrition using novel methodological approaches.
The proposed research is significant because it will lead to the development of evidence-based interventions to treat sarcopenia and muscle wasting.
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77555
- UTMB
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
61 years to 76 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 65-80 yrs
- Stable body weight for at least 1 year
- Ability to sign consent form:
Exclusion Criteria:
- Exercise training (>2 weekly sessions of moderate to high intensity aerobic or resistance exercise)
- Physical dependence or frailty (impairment in the Activities of Daily Living (ADL), history of falls (>2/year), or >5% weight loss in the past year)
- Significant heart, liver, kidney, blood, or respiratory disease
- Peripheral vascular disease
- Diabetes mellitus or other untreated endocrine disease
- Active cancer
- Acute infectious disease or history of chronic infections
- Recent (within 3 months) treatment with anabolic steroids, or prolonged systemic corticosteroids.
- Alcohol or drug abuse
- Tobacco use (smoking or chewing)
- Malnutrition (BMI < 18.5 kg/sq meter)
- Obesity (BMI > 30 kg/sq meter)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise
Determining the effect of 12 weeks of resistance training exercise on the response of muscle amino acid sensing
|
Progressive resistance exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle protein synthesis in response to amino acids
Time Frame: Change from baseline to 3 months
|
Measurement of the change in muscle protein synthesis in response to amino acids by standard stable isotope method
|
Change from baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle mass
Time Frame: Change from baseline to 3 months
|
Measurement in the change in muscle mass by DEXA scan
|
Change from baseline to 3 months
|
|
Muscle function
Time Frame: Change from baseline to 3 months
|
Measurement of the change in muscle function by standard methods
|
Change from baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Blake B Rasmussen, PhD, University of Texas
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
December 21, 2016
Study Completion (Actual)
December 21, 2016
Study Registration Dates
First Submitted
December 9, 2016
First Submitted That Met QC Criteria
December 16, 2016
First Posted (Estimate)
December 21, 2016
Study Record Updates
Last Update Posted (Actual)
June 13, 2018
Last Update Submitted That Met QC Criteria
June 11, 2018
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 15-0226
- R56AG051267 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nutrient Sensing
-
Leiden University Medical CenterCentre for Medical Systems BiologyCompletedNutrient Sensing During a Prolonged FastNetherlands
-
Northumbria UniversityWithdrawnBlood Glucose | Appetite | Intestinal Absorption | Nutrient Sensing | Taste ReceptorsUnited Kingdom
-
NHS LothianNot yet recruitingEndovascular Procedures | Force Sensing Surgical GlovesUnited Kingdom
-
Standard Process Inc.UNC Nutrition Research InstituteNot yet recruitingNutrient Intake Inadequacy | Nutrient Intake
-
Johns Hopkins Bloomberg School of Public HealthUNICEF; Vitamin Angels; Child and Family Foundation of Uganda; Kirk HumanitarianRecruitingNutrient DeficiencyUganda
-
Shape Divine Center SRLSmartepigenetX SRL; Advanced Nutrigenomics LLCCompleted
-
University of California, San FranciscoUniversity of Colorado, Denver; University of California, Davis; Post Graduate...CompletedNutrient DeficiencyIndia
-
University of British ColumbiaNot yet recruiting
-
DSM Nutritional Products, Inc.Sprim Advanced Life SciencesCompleted
-
Tufts UniversityMB Clinical Research and Consulting LLCCompletedNutrient DeficiencyUnited States
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Center for Health, Exercise and Sport Sciences,...CompletedSedentary LifestyleSerbia
-
Heitor Moreno JuniorUnknown
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting